Mark Gergen

Mark Gergen

Chairman chez POSEIDA THERAPEUTICS, INC.

Fortune : 2 M $ au 31/03/2024

61 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mark J.
Gergen
is currently the Executive Chairman at Poseida Therapeutics, Inc. and an Independent Director at Aristea Therapeutics, Inc. He previously worked as a Director at Aperio Technologies, Inc., Chief Financial & Development Officer at Advanced Tissue Sciences, Inc., Senior Vice President-Corporate Development at Amylin Pharmaceuticals, Inc., Principal at Jostens, Inc., Principal at Medtronic, Inc., Chief Operating Officer & Senior Vice President at Halozyme Therapeutics, Inc., Executive Vice President at CardioNet LLC, Principal at Premier Healthcare Solutions, Inc., and Chief Operating Officer, Secretary & Executive VP at Mirati Therapeutics, Inc. Mr. Gergen obtained his undergraduate degree from Minot State University and his graduate degree from The University of Minnesota Law School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/03/2024 651 291 ( 0,67% ) 2 M $ 31/03/2024

Postes actifs de Mark Gergen

SociétésPosteDébut
POSEIDA THERAPEUTICS, INC. Chairman 01/02/2023
Director/Board Member 24/08/2022
Tous les postes actifs de Mark Gergen

Anciens postes connus de Mark Gergen

SociétésPosteFin
HALOZYME THERAPEUTICS, INC. Chief Operating Officer 29/09/2017
MIRATI THERAPEUTICS Chief Operating Officer 16/09/2016
Corporate Officer/Principal 01/11/2012
Corporate Officer/Principal 01/03/2005
Advanced Tissue Sciences, Inc. Director of Finance/CFO -
Voir l'expérience en détail de Mark Gergen

Formation de Mark Gergen

Minot State University Undergraduate Degree
The University of Minnesota Law School Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark Gergen

Relations

100 +

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
HALOZYME THERAPEUTICS, INC.

Health Technology

POSEIDA THERAPEUTICS, INC.

Health Technology

Entreprise privées9
Advanced Tissue Sciences, Inc.

Commercial Services

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mark Gergen